These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 30497239)

  • 1. [Analyses of data from randomised trials].
    Skovlund E; Lydersen S
    Tidsskr Nor Laegeforen; 2018 Nov; 138(19):. PubMed ID: 30497239
    [No Abstract]   [Full Text] [Related]  

  • 2. Covariate adjustment and estimation of mean response in randomised trials.
    Bartlett JW
    Pharm Stat; 2018 Sep; 17(5):648-666. PubMed ID: 29998483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing assumptions for statistical analyses in randomised clinical trials.
    Nielsen EE; Nørskov AK; Lange T; Thabane L; Wetterslev J; Beyersmann J; de Uña-Álvarez J; Torri V; Billot L; Putter H; Winkel P; Gluud C; Jakobsen JC
    BMJ Evid Based Med; 2019 Oct; 24(5):185-189. PubMed ID: 30948454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of generalized linear mixed model procedures with estimating equations for variance and covariance parameter estimation in longitudinal studies and group randomized trials.
    Mehrotra DV
    Stat Med; 2002 Dec; 21(23):3745-7;author reply 3747-8. PubMed ID: 12436468
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomised controlled trials: the importance of sample size.
    Sedgwick P
    BMJ; 2015 Mar; 350():h1586. PubMed ID: 25801454
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomised controlled trials (RCTs)--essentials.
    Chan YH
    Singapore Med J; 2003 Feb; 44(2):60-3. PubMed ID: 14503778
    [No Abstract]   [Full Text] [Related]  

  • 7. Concealed allocation in randomised trials.
    Elkins M
    J Physiother; 2013 Jun; 59(2):134-6. PubMed ID: 23663807
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of cluster randomised trials with an assessment of outcome at baseline.
    Hooper R; Forbes A; Hemming K; Takeda A; Beresford L
    BMJ; 2018 Mar; 360():k1121. PubMed ID: 29559436
    [No Abstract]   [Full Text] [Related]  

  • 9. Strategy for randomised clinical trials in rare cancers.
    Tan SB; Dear KB; Bruzzi P; Machin D
    BMJ; 2003 Jul; 327(7405):47-9. PubMed ID: 12842959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Issues in the planning and conduct of randomised trials.
    Bhandari M; Pape HC; Giannoudis PV
    Injury; 2006 Apr; 37(4):349-54. PubMed ID: 16487524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimum number of clusters and comparison of analysis methods for cross sectional stepped wedge cluster randomised trials with binary outcomes: A simulation study.
    Barker D; D'Este C; Campbell MJ; McElduff P
    Trials; 2017 Mar; 18(1):119. PubMed ID: 28279222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CACE for assessing non-compliance: Addressing non-compliance in randomised controlled trials.
    Simmons RA; Egger JR
    BJOG; 2019 Dec; 126(13):1558-1559. PubMed ID: 31222924
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomised controlled trials: missing data.
    Marston L; Sedgwick P
    BMJ; 2014 Jul; 349():g4656. PubMed ID: 25038075
    [No Abstract]   [Full Text] [Related]  

  • 14. Association between bibliometric parameters, reporting and methodological quality of randomised controlled trials in vascular and endovascular surgery.
    Hajibandeh S; Hajibandeh S; Antoniou GA; Green PA; Maden M; Torella F
    Vascular; 2017 Apr; 25(2):196-207. PubMed ID: 27252347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised controlled trials in oncology closed early for benefit: trends in methodology, results, and interpretation.
    Booth CM; Ohorodnyk P; Zhu L; Tu D; Meyer RM
    Eur J Cancer; 2011 Apr; 47(6):854-63. PubMed ID: 21296570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When and how to use data from randomised trials to develop or validate prognostic models.
    Pajouheshnia R; Groenwold RHH; Peelen LM; Reitsma JB; Moons KGM
    BMJ; 2019 May; 365():l2154. PubMed ID: 31142454
    [No Abstract]   [Full Text] [Related]  

  • 17. Interpreting treatment effects in randomised trials.
    Guyatt GH; Juniper EF; Walter SD; Griffith LE; Goldstein RS
    BMJ; 1998 Feb; 316(7132):690-3. PubMed ID: 9522799
    [No Abstract]   [Full Text] [Related]  

  • 18. Finding the Pathway: Mediation Analyses in Randomized Controlled Trials.
    Localio AR; Meibohm AR; Guallar E
    Ann Intern Med; 2020 Apr; 172(8):553-557. PubMed ID: 32203981
    [No Abstract]   [Full Text] [Related]  

  • 19. Statistical testing for baseline differences between randomised groups is not meaningful.
    Harvey LA
    Spinal Cord; 2018 Oct; 56(10):919. PubMed ID: 30287888
    [No Abstract]   [Full Text] [Related]  

  • 20. Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards.
    Dehbi HM; Royston P; Hackshaw A
    BMJ; 2017 May; 357():j2250. PubMed ID: 28546261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.